AMR Action Fund invests in first European antimicrobial company
AMR joins a Series C funding raise for BioVersys, which is developing antimicrobials against common drug-resistant bacteria that threaten public health.
Archives for January 16, 2023
Manufacturing impurity delays Phathom’s drug commercialization
The FDA found traces of a nitrosamine in batches of vonoprazan, delaying the commercialization of the product and its application for an additional indication.
Florida woman jailed for lying to FDA about children's drugs trial
A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.